Onconova Therapeutics, Inc. reports $5.8 million Q1 loss

Onconova Therapeutics, Inc. [ONTX] has reported fiscal Q1 loss of $5.80 million.

On a per-share basis, the DE based company said its diluted earnings are $0.28.

The Pharmaceutical Preparations firm posted revenue of $0.56 million in this period.

Also Read:

• Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
• Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on ...
• Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with ...
• Onconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium
• Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify ...